These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2458549)

  • 1. Treatment of Guillain-Barré syndrome with high-dose gammaglobulin.
    Kleyweg RP; van der Meché FG; Meulstee J
    Neurology; 1988 Oct; 38(10):1639-41. PubMed ID: 2458549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose intravenous immunoglobulin in the treatment of Guillain-Barré syndrome: a preliminary open study.
    Jackson MC; Godwin-Austen RB; Whiteley AM
    J Neurol; 1993 Jan; 240(1):51-3. PubMed ID: 7678640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of the Guillain-Barre syndrome with intravenous gammaglobulin. Presentation of a case].
    Barriales V; Velasco L; Moral A; Sánchez Navarro J
    Med Clin (Barc); 1990 Mar; 94(10):399. PubMed ID: 1692387
    [No Abstract]   [Full Text] [Related]  

  • 4. High-dose intravenous gammaglobulin in Guillain-Barré syndrome.
    van der Meché FG; Kleyweg RP; Meulstee J; Oomes PG
    Ann Neurol; 1988 Oct; 24(4):588. PubMed ID: 2467602
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of high-dose gammaglobulin on a case of Guillain-Barré syndrome].
    Ishikawa A; Tanaka S; Fukushima N; Takase A; Wagatsuma Y; Kikuta H; Azuma H
    No To Hattatsu; 1993 May; 25(3):263-6. PubMed ID: 7686017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Guillain-Barré syndrome: response to high dose intravenous gammaglobulin therapy in a 12-year old girl].
    Aguayo Maldonado J; Casanovas Lax J; Rodríguez Medina J; del Rey Moreno J; Jiménez Hernández MD; Cruz Guerrero G
    An Esp Pediatr; 1991 Aug; 35(2):141-2. PubMed ID: 1719850
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dramatic improvement with immunoabsorption therapy in a 7-year-old girl with severe Guillain-Barré syndrome after unsuccessful gammaglobulin therapy].
    Watanabe T; Matsuura O; Natsume J; Kubota T; Nakashima S; Aso K; Negoro T; Watanabe K
    No To Hattatsu; 1998 May; 30(3):255-60. PubMed ID: 9613160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High dose intravenous immune globulins and plasma exchange in Guillain-Barré Syndrome.
    Ravasio A; Pasquinelli M; Currò Dossi B; Neri W; Guidi C; Gessaroli M; Rasi F; Fabbri R; Mazzini G; Rebucci GG
    Ital J Neurol Sci; 1995 Oct; 16(7):487-92. PubMed ID: 8749707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The treatment of Guillain-Barré syndrome with high gamma-globulin doses].
    Bilbao J; Trejo JM; Feijóo M
    Med Clin (Barc); 1990 Sep; 95(9):359. PubMed ID: 1704085
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma exchange and i.v.-immunoglobulins: new approaches to the treatment of Guillain-Barre' syndrome.
    Fasanaro AM; Pizza V; Stella L
    Acta Neurol (Napoli); 1992; 14(4-6):369-80. PubMed ID: 1293980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of Guillain-Barré syndrome associated with SIADH, treated by intravenous gammaglobulins].
    De Decker V; Pera SB; Borenstein S; Tombroff M
    Acta Clin Belg; 1996; 51(3):170-4. PubMed ID: 8766218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulins i.v.: a new approach to the treatment of Guillain-Barré syndrome.
    Fasanaro AM; Pizza V; Rossi V
    Minerva Med; 1996; 87(1-2):17-20. PubMed ID: 8610020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose intravenous immune globulin in the management of severe Guillain-Barre syndrome.
    Baskin E; Turkay S; Icagasioglu D; Tanzer F; Cevit O
    Turk J Pediatr; 1996; 38(1):119-23. PubMed ID: 8819632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose intravenous immune globulin in the management of severe Guillain-Barre syndrome.
    Urtasun M; López de Munain A; Carrera N; Martí-Massó JF; López de Dicastillo G; Mozo C
    Ann Pharmacother; 1992 Jan; 26(1):32-3. PubMed ID: 1606342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Guillain-Barré syndrome with high-dose immune globulins combined with methylprednisolone: a pilot study. The Dutch Guillain-Barré Study Group.
    Ann Neurol; 1994 Jun; 35(6):749-52. PubMed ID: 8210234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe Guillain-Barré syndrome during childhood responding to intravenous gammaglobulin.
    Heaton PA
    N Z Med J; 1992 Nov; 105(946):477-8. PubMed ID: 1436876
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment related fluctuations in Guillain-Barré syndrome after high-dose immunoglobulins or plasma-exchange.
    Kleyweg RP; van der Meché FG
    J Neurol Neurosurg Psychiatry; 1991 Nov; 54(11):957-60. PubMed ID: 1800666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group.
    van der Meché FG; Schmitz PI
    N Engl J Med; 1992 Apr; 326(17):1123-9. PubMed ID: 1552913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin treatment in children with Guillain-Barre syndrome.
    Gürses N; Uysal S; Cetinkaya F; Işlek I; Kalayci AG
    Scand J Infect Dis; 1995; 27(3):241-3. PubMed ID: 8539548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of dermatomyositis with intravenous gammaglobulin.
    Lang BA; Laxer RM; Murphy G; Silverman ED; Roifman CM
    Am J Med; 1991 Aug; 91(2):169-72. PubMed ID: 1714236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.